Tech Company Financing Transactions
Hexagon Bio Funding Round
Nextech Invest, 8VC and Casdin Capital invested in a $61 million venture round for Hexagon Bio. The round was recorded on 9/23/2021.
Transaction Overview
Company Name
Announced On
9/23/2021
Transaction Type
Venture Equity
Amount
$61,000,000
Round
Undisclosed
Investors
Nextech Invest (Lead Investor) (Jakob Loven)
8VC (Alex Kolicich)
The Column Group (David Goeddel)
Two Sigma Ventures (Dusan Perovic)
Proceeds Purpose
Proceeds from the financing will enable the company to further expand its genomics database and accelerate its drug discovery efforts with an initial focus on high-value anti-infective and oncology targets.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1490 O'Brien Dr. E
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Undisclosed
Website
Email Address
Overview
Hexagon Bio's mission to identify medicines encoded in the global metagenome, and bring them to patients. While nature's molecules have proven to be a rich source of potent medicines, their translation has been laborious and hindered by the lack of mechanistic understanding of the intended target.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Maureen Hillenmeyer
Founder
Colin Harvey
Founder
Brian Naughton
Founder
Yi Tang
Vice President
James Li
VP - Bus. Development
Sofia Touami
VP - Engineering
Andrew Aymeloglu
Browse more venture capital transactions:
Prev: 9/23/2021: Pearl Health venture capital transaction
Next: 9/23/2021: Mainfactor venture capital transaction
Share this article
About Database of VC Transactions
We report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs